Repare Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Repare Therapeutics

09/05/2023 21:55

* Repare Therapeutics Inc  RPTX.OQ  reported a quarterly
adjusted
loss of 83 cents​​ per share for the quarter ended in March. The
mean expectation of seven analysts for the quarter was for a
loss of 81 cents per share.
    * Revenue rose 1,291.7% to $5.68 million from a year ago;
analysts
expected $6.12 million. 
    * Repare Therapeutics Inc's reported EPS for the quarter was
a
loss of 83 cents​.
    * The mean earnings estimate of analysts had risen by
about 4.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Repare Therapeutics Inc shares had risen by 5.9% this
quarter and lost 29.2% so far this year.
    * The company reported a quarterly loss of $34.75 million.
    * Wall Street's median 12-month price target for Repare
Therapeutics Inc is $28.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
9 at 08:55 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.81          -0.83          Missed
 Dec. 31 2022      -0.72          -0.75          Missed
 Sep. 30 2022      -0.89          1.71           Beat
 Jun. 30 2022      -0.85          -0.91          Missed